药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Benzethidine
Anti-inhibitor coagulant complex
The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Nafamostat.
Benzethidine
Coagulation factor VII human
The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Nafamostat.
Benzethidine
Coagulation factor X human
The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Nafamostat.
Benzethidine
Von Willebrand Factor Human
The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Nafamostat.
Benzethidine
Factor XIII (human)
The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Nafamostat.
Benzethidine
Vatreptacog alfa
The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Nafamostat.
Benzethidine
Rusalatide acetate
The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Nafamostat.
Benzethidine
Eftrenonacog alfa
The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Nafamostat.
Benzethidine
Susoctocog alfa
The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Nafamostat.
Benzethidine
Factor IX Complex (Human)
The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Nafamostat.
Benzethidine
Prothrombin
The therapeutic efficacy of Prothrombin can be decreased when used in combination with Nafamostat.
Benzethidine
Calcium threonate
The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Nafamostat.
Benzethidine
Calcium gluconate
The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Nafamostat.
Benzethidine
Antihemophilic Factor (Recombinant), PEGylated
The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Nafamostat.
Benzethidine
Catridecacog
The therapeutic efficacy of Catridecacog can be decreased when used in combination with Nafamostat.
Benzethidine
Fibrinogen human
The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Nafamostat.
Benzethidine
Turoctocog alfa
The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Nafamostat.
Benzethidine
Calcium carbonate
The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Nafamostat.
Benzethidine
Pantothenic acid
The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Nafamostat.
Benzethidine
Omega-3-carboxylic acids
The therapeutic efficacy of Nafamostat can be increased when used in combination with Omega-3-carboxylic acids.